[Answered] With memos, an in-house audience is usually a A) Specialist. B) Semi-specialist. C) Lay audience. ...

This topic contains a solution. Click here to go to the answer

Author Question: With memos, an in-house audience is usually a A) Specialist. B) Semi-specialist. C) Lay audience. ... (Read 74 times)

ARLKQ

Hero Member
Posts: 571

on: Jun 23, 2018

With memos, an in-house audience is usually a

A) Specialist. B) Semi-specialist. C) Lay audience. D) All of the above. E) A and B.

Question 2

In the body of your memo, the longer the paragraph, the more likely your audience will be to

A) Analyze the key points. B) Avoid reading. C) Read more carefully. D) None of the above.

Need homework help now?

Ask unlimited questions for free

Ask a Question

Marked as best answer by a Subject Expert

amit

Sr. Member
Posts: 364

Reply #1 on: Jun 23, 2018

Answer to Question 1

E

Answer to Question 2

B

ARLKQ

Member
Posts: 571

Reply 2 on: Jun 23, 2018

TYSM

vickyvicksss

Member
Posts: 351

Reply 3 on: Yesterday

Great answer, keep it coming

« previous next »

Did you know?

The lipid bilayer is made of phospholipids. They are arranged in a double layer because one of their ends is attracted to water while the other is repelled by water.

Did you know?

Approximately one in three babies in the United States is now delivered by cesarean section. The number of cesarean sections in the United States has risen 46% since 1996.

Did you know?

The cure for trichomoniasis is easy as long as the patient does not drink alcoholic beverages for 24 hours. Just a single dose of medication is needed to rid the body of the disease. However, without proper precautions, an individual may contract the disease repeatedly. In fact, most people develop trichomoniasis again within three months of their last treatment.

Did you know?

The U.S. Preventive Services Task Force recommends that all women age 65 years of age or older should be screened with bone densitometry.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.